Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidative damage to hyaluronan-CD44 interactions as an underlying mechanism of action of oxidative stress-inducing cancer therapy. | Redox Biol | 2021 | 33895486 | PubTator, text mining | PubMed |
| Extracellular matrix and its therapeutic potential for cancer treatment. | Signal Transduct Target Ther | 2021 | 33888679 | PubTator, text mining | PubMed |
| Molecular insights of hyaluronic acid-hydroxychloroquine conjugate as a promising drug in targeting SARS-CoV-2 viral proteins. | J Mol Struct | 2021 | 33867575 | PubTator, text mining | PubMed |
| Wobble tRNA modification and hydrophilic amino acid patterns dictate protein fate. | Nat Commun | 2021 | 33859181 | PubTator, text mining | PubMed |
| Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods. | BMC Med Genomics | 2021 | 33849532 | PubTator, text mining | PubMed |
| Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma. | World J Surg Oncol | 2021 | 33845847 | PubTator, text mining | PubMed |
| TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. | Int J Mol Sci | 2021 | 33807717 | PubTator, text mining | PubMed |
| The Secreted Protein C10orf118 Is a New Regulator of Hyaluronan Synthesis Involved in Tumour-Stroma Cross-Talk. | Cancers (Basel) | 2021 | 33807583 | PubTator, text mining | PubMed |
| Biomedical Applications of Bacteria-Derived Polymers. | Polymers (Basel) | 2021 | 33805506 | PubTator, text mining | PubMed |
| Hyaluronan Synthases' Expression and Activity Are Induced by Fluid Shear Stress in Bone Marrow-Derived Mesenchymal Stem Cells. | Int J Mol Sci | 2021 | 33803805 | PubTator, text mining | PubMed |
| Interactions of Meibum and Tears with Mucomimetic Polymers: A Hint towards the Interplay between the Layers of the Tear Film. | Int J Mol Sci | 2021 | 33803116 | PubTator, text mining | PubMed |
| Transcriptome Analysis Identifies Novel Mechanisms Associated with the Antitumor Effect of Chitosan-Stabilized Selenium Nanoparticles. | Pharmaceutics | 2021 | 33800318 | PubTator, text mining | PubMed |
| Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy. | Biomolecules | 2021 | 33800172 | PubTator, text mining | PubMed |
| NMR Characterization of the Interactions Between Glycosaminoglycans and Proteins. | Front Mol Biosci | 2021 | 33796549 | PubTator, text mining | PubMed |
| Hyaluronan-Mediated Motility Receptor Governs Chromosome Segregation by Regulating Microtubules Sliding Within the Bridging Fiber. | Adv Biol (Weinh) | 2021 | 33788418 | PubTator, text mining | PubMed |
| Six genes involved in prognosis of hepatocellular carcinoma identified by Cox hazard regression. | BMC Bioinformatics | 2021 | 33784984 | PubTator, text mining | PubMed |
| Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. | PeerJ | 2021 | 33777535 | PubTator, text mining | PubMed |
| Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. | Immunity | 2021 | 33765435 | PubTator, text mining | PubMed |
| Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis. | Adv Healthc Mater | 2021 | 33763992 | PubTator, text mining | PubMed |
| High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2021 | 33763352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=42